Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin
Clinical trial NCT05654298 · COMPLETED
Trial details
- NCT number
- NCT05654298
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-15
- Primary completion
- 2023-03-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.